Research has shown that patients are likely to participate when they are aware of clinical trial opportunities and are empowered with knowledge to optimize their engagement experiences. In rare diseases, these problems are further amplified.

TORONTO (PRWEB)
November 05, 2020

New medicines are made possible by participation in clinical trials and patient recruitment is often the rate limiting step in bringing new therapies to market. Research has shown that patients are likely to participate when they are aware of clinical trial opportunities and are empowered with knowledge to optimize their engagement experiences. In rare diseases, these problems are further amplified.

In this webinar, learn how Medidata is improving access to, and optimizing experiences in, clinical trials through myMedidata.

Join Kelly McKee, Senior Director of Patient Registries and Recruitment, Medidata – a Dassault Systèmes company – in a live webinar on Wednesday, November 18, 2020 at 1pm EST (10am PST).

For more information, or to register for this event, visit Improving Access to Clinical Trials for Rare Disease Patients Through Registries.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: